How to train your myeloid cells: a way forward for helminth vaccines?
Open Access
- 30 May 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1163364
Abstract
Soil-transmitted helminths affect approximately 1.5 billion people worldwide. However, as no vaccine is currently available for humans, the current strategy for elimination as a public health problem relies on preventive chemotherapy. Despite more than 20 years of intense research effort, the development of human helminth vaccines (HHVs) has not yet come to fruition. Current vaccine development focuses on peptide antigens that trigger strong humoral immunity, with the goal of generating neutralizing antibodies against key parasite molecules. Notably, this approach aims to reduce the pathology of infection, not worm burden, with only partial protection observed in laboratory models. In addition to the typical translational hurdles that vaccines struggle to overcome, HHVs face several challenges (1): helminth infections have been associated with poor vaccine responses in endemic countries, probably due to the strong immunomodulation caused by these parasites, and (2) the target population displays pre-existing type 2 immune responses to helminth products, increasing the likelihood of adverse events such as allergy or anaphylaxis. We argue that such traditional vaccines are unlikely to be successful on their own and that, based on laboratory models, mucosal and cellular-based vaccines could be a way to move forward in the fight against helminth infection. Here, we review the evidence for the role of innate immune cells, specifically the myeloid compartment, in controlling helminth infections. We explore how the parasite may reprogram myeloid cells to avoid killing, notably using excretory/secretory (ES) proteins and extracellular vesicles (EVs). Finally, learning from the field of tuberculosis, we will discuss how anti-helminth innate memory could be harnessed in a mucosal-trained immunity-based vaccine.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PR00P3_193084)
This publication has 229 references indexed in Scilit:
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infectionNature Medicine, 2012
- Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of T H 2 InflammationScience, 2011
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Helminth Cysteine Proteases Inhibit TRIF-dependent Activation of Macrophages via Degradation of TLR3Journal of Biological Chemistry, 2010
- Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor CellsJournal of Biological Chemistry, 2009
- MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophagesJournal of Leukocyte Biology, 2009
- Adaptive immune features of natural killer cellsNature, 2009
- Necator americanus: The Na-ASP-2 protein secreted by the infective larvae induces neutrophil recruitment in vivo and in vitroExperimental Parasitology, 2008
- Schistosoma mansoni infection in eosinophil lineage–ablated miceBlood, 2006